BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 16407991)

  • 1. Activity-based probes that target diverse cysteine protease families.
    Kato D; Boatright KM; Berger AB; Nazif T; Blum G; Ryan C; Chehade KA; Salvesen GS; Bogyo M
    Nat Chem Biol; 2005 Jun; 1(1):33-8. PubMed ID: 16407991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of aza-peptide electrophile activity-based probes of caspases.
    Sexton KB; Kato D; Berger AB; Fonovic M; Verhelst SH; Bogyo M
    Cell Death Differ; 2007 Apr; 14(4):727-32. PubMed ID: 17170749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases.
    Verhelst SH; Witte MD; Arastu-Kapur S; Fonovic M; Bogyo M
    Chembiochem; 2006 Jun; 7(6):943-50. PubMed ID: 16607671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic imaging of protease activity with fluorescently quenched activity-based probes.
    Blum G; Mullins SR; Keren K; Fonovic M; Jedeszko C; Rice MJ; Sloane BF; Bogyo M
    Nat Chem Biol; 2005 Sep; 1(4):203-9. PubMed ID: 16408036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of alpha,beta-unsaturated ketone-based probes for papain-family cysteine proteases.
    Yang Z; Fonović M; Verhelst SH; Blum G; Bogyo M
    Bioorg Med Chem; 2009 Feb; 17(3):1071-8. PubMed ID: 18343672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general solid phase method for the preparation of diverse azapeptide probes directed against cysteine proteases.
    Kato D; Verhelst SH; Sexton KB; Bogyo M
    Org Lett; 2005 Dec; 7(25):5649-52. PubMed ID: 16321013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis of peptide vinyl sulfones as potential inhibitors and activity-based probes of cysteine proteases.
    Wang G; Mahesh U; Chen GY; Yao SQ
    Org Lett; 2003 Mar; 5(5):737-40. PubMed ID: 12605503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics.
    Dragovich PS; Prins TJ; Zhou R; Fuhrman SA; Patick AK; Matthews DA; Ford CE; Meador JW; Ferre RA; Worland ST
    J Med Chem; 1999 Apr; 42(7):1203-12. PubMed ID: 10197964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodioxocin-3-ones and N-acyl-3-amino-3-buten-2-ones: novel classes of cathepsin K cysteine protease inhibitors.
    Yamashita DS; Xie R; Lin H; Wang B; Shi SD; Quinn CJ; Hemling ME; Hissong C; Tomaszek TA; Veber DF
    J Pept Res; 2004 Mar; 63(3):265-9. PubMed ID: 15049838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding.
    Vincents B; von Pawel-Rammingen U; Björck L; Abrahamson M
    Biochemistry; 2004 Dec; 43(49):15540-9. PubMed ID: 15581366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic techniques and activity-based probes for the system-wide study of proteolysis.
    auf dem Keller U; Schilling O
    Biochimie; 2010 Nov; 92(11):1705-14. PubMed ID: 20493233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.
    Berger AB; Witte MD; Denault JB; Sadaghiani AM; Sexton KM; Salvesen GS; Bogyo M
    Mol Cell; 2006 Aug; 23(4):509-21. PubMed ID: 16916639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors.
    Nazif T; Bogyo M
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):2967-72. PubMed ID: 11248015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases).
    James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC
    Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum: biochemical characterization of the cysteine protease falcipain-2'.
    Singh N; Sijwali PS; Pandey KC; Rosenthal PJ
    Exp Parasitol; 2006 Mar; 112(3):187-92. PubMed ID: 16337629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.
    Desai PV; Patny A; Gut J; Rosenthal PJ; Tekwani B; Srivastava A; Avery M
    J Med Chem; 2006 Mar; 49(5):1576-84. PubMed ID: 16509575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Synthesis of Activity-Based Probes and Inhibitors for Bleomycin Hydrolase.
    van der Linden WA; Segal E; Child MA; Byzia A; Drąg M; Bogyo M
    Chem Biol; 2015 Aug; 22(8):995-1001. PubMed ID: 26256478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of a highly specific, endogenous inhibitor of cysteine protease from Staphylococcus epidermidis, a new member of the staphostatin family.
    Dubin G; Stec-Niemczyk J; Dylag T; Silberring J; Dubin A; Potempa J
    Biol Chem; 2004 Jun; 385(6):543-6. PubMed ID: 15255187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probes for activity-based profiling of plant proteases.
    van der Hoorn RA; Kaiser M
    Physiol Plant; 2012 May; 145(1):18-27. PubMed ID: 21985675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.
    Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K
    Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.